Treatment options for patients with HR+/HER2− advanced breast cancer during the COVID-19 pandemic: dose reduction of ribociclib does not diminish efficacy

Volume: 182, Issue: 1, Pages: 243 - 244
Published: May 20, 2020
Abstract
No abstract.
Paper Details
Title
Treatment options for patients with HR+/HER2− advanced breast cancer during the COVID-19 pandemic: dose reduction of ribociclib does not diminish efficacy
Published Date
May 20, 2020
Volume
182
Issue
1
Pages
243 - 244
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.